MNKD FY 2021 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$75M+15.8% YoY

Gross Profit

$37M48.5% margin

Operating Income

-$47M-62.3% margin

Net Income

-$81M-107.3% margin

EPS (Diluted)

$-0.37

Cash Flow

Operating Cash Flow

-$62M

Free Cash Flow

-$73M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$321M

Total Liabilities

$531M

Stockholders' Equity

-$209M

Cash & Equivalents

$124M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$75M	$65M	+15.8%
Gross Profit	$37M	$41M	-9.7%
Operating Income	-$47M	-$48M	+1.9%
Net Income	-$81M	-$57M	-41.4%